rs774103118

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001191061.2(SLC25A22):​c.967G>A​(p.Ala323Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000277 in 1,445,042 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000028 ( 0 hom. )

Consequence

SLC25A22
NM_001191061.2 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.707

Publications

0 publications found
Variant links:
Genes affected
SLC25A22 (HGNC:19954): (solute carrier family 25 member 22) This gene encodes a mitochondrial glutamate carrier. Mutations in this gene are associated with early infantile epileptic encephalopathy. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jul 2010]
SLC25A22 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • developmental and epileptic encephalopathy, 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • early myoclonic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.079891056).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001191061.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC25A22
NM_001191061.2
MANE Select
c.967G>Ap.Ala323Thr
missense
Exon 10 of 10NP_001177990.1Q9H936
SLC25A22
NM_001425334.1
c.1042G>Ap.Ala348Thr
missense
Exon 10 of 10NP_001412263.1
SLC25A22
NM_001425335.1
c.1006G>Ap.Ala336Thr
missense
Exon 10 of 10NP_001412264.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC25A22
ENST00000628067.3
TSL:1 MANE Select
c.967G>Ap.Ala323Thr
missense
Exon 10 of 10ENSP00000486058.1Q9H936
SLC25A22
ENST00000320230.9
TSL:1
c.967G>Ap.Ala323Thr
missense
Exon 10 of 10ENSP00000322020.5Q9H936
SLC25A22
ENST00000860087.1
c.1042G>Ap.Ala348Thr
missense
Exon 10 of 10ENSP00000530146.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.0000135
AC:
3
AN:
222696
AF XY:
0.0000243
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000595
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000992
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000277
AC:
4
AN:
1445042
Hom.:
0
Cov.:
31
AF XY:
0.00000556
AC XY:
4
AN XY:
719052
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33310
American (AMR)
AF:
0.0000678
AC:
3
AN:
44268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25966
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39528
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85384
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42432
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4146
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1110144
Other (OTH)
AF:
0.00
AC:
0
AN:
59864
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Developmental and epileptic encephalopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.014
T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.66
T
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.080
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.71
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.18
N
REVEL
Benign
0.28
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Varity_R
0.20
gMVP
0.40
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs774103118; hg19: chr11-791920; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.